coronary revascularization procedure

coronary revascularization procedure

Cardiology Any procedure–eg, CABG, PTCA, stenting, used to ↑ coronary artery blood flow. See Balloon angioplasty, Coronary artery bypass graft, Coronary artery stent.
Mentioned in ?
References in periodicals archive ?
7 years, the primary outcome - a composite of incident coronary heart disease, congestive heart failure, heart attack, coronary revascularization procedure, ischemic stroke, peripheral arterial disease and cardiovascular death - occurred in 8.
A case-control study conducted in Finland that included 85 men who had had a coronary revascularization procedure found that those with early-onset alopecia had a "nearly significant" odds ratio of 1.
8 years of follow-up, 29% of the participants had a first cardiovascular event consisting of acute MI, congestive heart failure, a coronary revascularization procedure, atrial fibrillation, stroke, transient ischemic attack, or cardiovascular death.
The study evaluated predictors of the primary LDL goal and secondary lipid thresholds as defined by the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III guidelines among 304 women hospitalized at three academic medical centers with an acute coronary syndrome, CHD, or a coronary revascularization procedure.
I look forward to working closely with the superb Regado executive team and Board as the company executes the ongoing Phase 3 REGULATE-PCI study, which has the potential to bring an important and unique new two-component anticoagulant system to cardiologists performing coronary revascularization procedures.
To assess temporal trends in coronary revascularization procedures, the investigators examined hospitalization claims using an Agency for Healthcare Research and Quality database.
Between 25,000 and 75,000 new cases of angina refractory to maximal medical therapy and standard coronary revascularization procedures are diagnosed each year.
chest pain and 27 percent fewer coronary revascularization procedures, such as
The Miracor PICSO([R]) Impulse System is CE-marked and can be used during coronary revascularization procedures following myocardial infarction and other types of acute coronary syndromes to intermittently increase the pressure in the coronary venous system.
The study is now in the observational phase with 10 years of follow-up, during which 517 clinically verified nonfatal MIs, strokes, coronary revascularization procedures, and cardiovascular deaths have occurred.
Regado is developing REG1 for use in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures.
If the results of this study further confirm the Phase 1 data, we are confident this system may be able to transform the way anticoagulation is approached in coronary revascularization procedures and other acute care settings.